Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Comparison of a quasi-dynamic and a static extraction method for the cytotoxic evaluation of acrylic bone cements.

Hoess A, López A, Engqvist H, Ott MK, Persson C.

Mater Sci Eng C Mater Biol Appl. 2016 May;62:274-82. doi: 10.1016/j.msec.2016.01.048. Epub 2016 Jan 21.

PMID:
26952424
2.

The effect of oligo(trimethylene carbonate) addition on the stiffness of acrylic bone cement.

Persson C, López A, Fathali H, Hoess A, Rojas R, Ott MK, Hilborn J, Engqvist H.

Biomatter. 2016;6:e1133394. doi: 10.1080/21592535.2015.1133394.

3.

The influence of Sr content in calcium phosphate coatings.

Lindahl C, Pujari-Palmer S, Hoess A, Ott M, Engqvist H, Xia W.

Mater Sci Eng C Mater Biol Appl. 2015 Aug;53:322-30. doi: 10.1016/j.msec.2015.04.015. Epub 2015 Apr 14.

PMID:
26042720
4.

Effects of nanoporous alumina on inflammatory cell response.

Pujari S, Hoess A, Shen J, Thormann A, Heilmann A, Tang L, Karlsson-Ott M.

J Biomed Mater Res A. 2014 Nov;102(11):3773-80. doi: 10.1002/jbm.a.35048. Epub 2013 Dec 9.

5.

Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data.

Combs SE, Kessel KA, Herfarth K, Jensen A, Oertel S, Blattmann C, Ecker S, Hoess A, Martin E, Witt O, Jäkel O, Kulozik AE, Debus J.

Radiat Oncol. 2012 Oct 17;7:170. doi: 10.1186/1748-717X-7-170.

6.

Self-supporting nanoporous alumina membranes as substrates for hepatic cell cultures.

Hoess A, Thormann A, Friedmann A, Heilmann A.

J Biomed Mater Res A. 2012 Sep;100(9):2230-8. doi: 10.1002/jbm.a.34158. Epub 2012 Apr 10.

PMID:
22492687
7.

Role of alumina nanoporosity in acute cell response.

Ferraz N, Hoess A, Thormann A, Heilmann A, Shen J, Tang L, Ott MK.

J Nanosci Nanotechnol. 2011 Aug;11(8):6698-704.

PMID:
22103070
8.

Mesoporous titanium dioxide coating for metallic implants.

Xia W, Grandfield K, Hoess A, Ballo A, Cai Y, Engqvist H.

J Biomed Mater Res B Appl Biomater. 2012 Jan;100(1):82-93. doi: 10.1002/jbm.b.31925. Epub 2011 Sep 27.

PMID:
21954047
9.

Acute toxicity of combined photon IMRT and carbon ion boost for intermediate-risk prostate cancer - acute toxicity of 12C for PC.

Nikoghosyan AV, Schulz-Ertner D, Herfarth K, Didinger B, Münter MW, Jensen AD, Jäkel O, Hoess A, Haberer T, Debus J.

Acta Oncol. 2011 Aug;50(6):784-90. doi: 10.3109/0284186X.2011.584558.

PMID:
21767175
10.

Investigation of cell-substrate interactions by focused ion beam preparation and scanning electron microscopy.

Friedmann A, Hoess A, Cismak A, Heilmann A.

Acta Biomater. 2011 Jun;7(6):2499-507. doi: 10.1016/j.actbio.2011.02.024. Epub 2011 Feb 21.

PMID:
21345385
11.

Low-modulus PMMA bone cement modified with castor oil.

López A, Hoess A, Thersleff T, Ott M, Engqvist H, Persson C.

Biomed Mater Eng. 2011;21(5-6):323-32. doi: 10.3233/BME-2012-0679.

PMID:
22561251
12.

Heidelberg Ion Therapy Center (HIT): Initial clinical experience in the first 80 patients.

Combs SE, Ellerbrock M, Haberer T, Habermehl D, Hoess A, Jäkel O, Jensen A, Klemm S, Münter M, Naumann J, Nikoghosyan A, Oertel S, Parodi K, Rieken S, Debus J.

Acta Oncol. 2010 Oct;49(7):1132-40. doi: 10.3109/0284186X.2010.498432.

PMID:
20831505
13.

Temporal lobe reactions after radiotherapy with carbon ions: incidence and estimation of the relative biological effectiveness by the local effect model.

Schlampp I, Karger CP, Jäkel O, Scholz M, Didinger B, Nikoghosyan A, Hoess A, Krämer M, Edler L, Debus J, Schulz-Ertner D.

Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):815-23. doi: 10.1016/j.ijrobp.2010.03.001. Epub 2010 Jul 16.

PMID:
20638186
14.

Time- and dose-dependency of radiographic normal tissue changes of the lung after stereotactic radiotherapy.

Hof H, Zgoda J, Nill S, Hoess A, Kopp-Schneider A, Herfarth K, Debus J, Plathow C.

Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1369-74. doi: 10.1016/j.ijrobp.2009.06.082. Epub 2009 Nov 24.

PMID:
19932943
15.

Quantitative assessment of image-guided radiotherapy for paraspinal tumors.

Stoiber EM, Lechsel G, Giske K, Muenter MW, Hoess A, Bendl R, Debus J, Huber PE, Thieke C.

Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):933-40. doi: 10.1016/j.ijrobp.2009.04.010.

PMID:
19596172
16.

Stereotactic single-dose radiotherapy of lung metastases.

Hof H, Hoess A, Oetzel D, Debus J, Herfarth K.

Strahlenther Onkol. 2007 Dec;183(12):673-8.

PMID:
18040611
17.

Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC).

Hof H, Muenter M, Oetzel D, Hoess A, Debus J, Herfarth K.

Cancer. 2007 Jul 1;110(1):148-55.

18.

Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy.

Combs SE, Thilmann C, Huber PE, Hoess A, Debus J, Schulz-Ertner D.

Cancer. 2007 Jun 1;109(11):2308-14.

19.

Cultivation of hepatoma cell line HepG2 on nanoporous aluminum oxide membranes.

Hoess A, Teuscher N, Thormann A, Aurich H, Heilmann A.

Acta Biomater. 2007 Jan;3(1):43-50. Epub 2006 Oct 24.

PMID:
17064971
20.

Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: the NEAR protocol (NCT00115518).

Jensen AD, Münter MW, Bischoff H, Haselmann R, Timke C, Krempien R, Sterzing F, Nill S, Heeger S, Hoess A, Haberkorn U, Huber PE, Steins M, Thomas M, Debus J, Herfarth KK.

BMC Cancer. 2006 May 8;6:122.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk